Cerebral palsy is a lifelong neurodevelopmental condition arising from non-progressive
disorders occurring in the fetal or infant brain. Cerebral palsy has long been categorised into …

Neonates with neonatal encephalopathy (NE) often present with multi-organ dysfunction that
requires multidisciplinary specialized management. Care of the neonate with NE is thus …

Intrapartum hypoxia–ischemia leading to neonatal encephalopathy (NE) results in
significant neonatal mortality and morbidity worldwide, with> 85% of cases occurring in low …

Neonatal encephalopathy (NE) is a “clinical syndrome of disturbed neurologic function in the
first week after birth in an infant born at or beyond 35 weeks of gestation, manifest by a …

Neonatal Encephalopathy (NE) is a major cause of lifelong disability and neurological
complications in affected infants. Identifying novel diagnostic biomarkers in this population …

Aim To review the evidence of the effects of neonatal magnesium sulphate for
neuroprotection in perinatal asphyxia and hypoxic‐ischaemic encephalopathy (HIE) …

Neuroinflammation is a leading cause of secondary neuronal injury in neonatal hypoxic-
ischemic encephalopathy (HIE). Regulation of neuroinflammation may be beneficial for …

Hypoxic-ischemic encephalopathy (HIE) is associated with excessive inflammation, blood-
brain barrier dysfunction, and oxidative stress. Irisin can reduce inflammation and ameliorate …

We use a case of intact cord resuscitation to argue for the beneficial effects of an enhanced
blood volume from placental transfusion for newborns needing resuscitation. We propose …

Background Therapeutic hypothermia (TH) is the gold-standard treatment for moderate and
severe neonatal encephalopathy (NE). Care during TH has implications for long-term …